Back to Show
Horizons from PBS News
The promise of obesity drugs and their potential risks
Season 2026
Episode 9
Once a relatively obscure class of drugs used for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects over 100 million Americans. Horizons moderator William Brangham explores the great promise of the drugs and the potential concerns surrounding them with Dr. Jody Dushay, Dr. Rekha B. Kumar, Dr. Anna Lembke and Dr. Ziyad Al-Aly.
Support Provided By
26:45
Exploring the science of keeping your mind sharp as you age
26:46
How a rare genetic mutation could unlock new ways to treat or prevent dementia
26:46
How much privacy is left in an age of surveillance?
26:46
The science of grief and how it can impact physical health
26:46
The lasting health toll of 9/11 on rescue workers and survivors
26:46
Technology is reshaping education. But is it helping students learn?
26:46
Why America faces a primary care shortage – and why it matters
26:49
The unsung heroes of American innovation and ingenuity
26:54
Why communities are revolting against data centers
26:46
The alarming decline of bird populations and why humans should care
26:46
Why uterine fibroids remain misunderstood despite affecting most women